About Shaperon
Shaperon is a company based in Seoul (South Korea) founded in 2008 by Seung Yong Seong.. The company has 54 employees as of December 31, 2024. Shaperon operates in a competitive market with competitors including Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics, Revance Therapeutics and Alpine Immune Sciences, among others.
- Headquarter Seoul, South Korea
- Employees 54 as on 31 Dec, 2024
- Founders Seung Yong Seong
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Shaperon Inc.
-
Annual Revenue
$12 K (USD)-91.77as on Dec 31, 2024
-
Net Profit
$-10.1 M (USD)-20.15as on Dec 31, 2024
-
EBITDA
$-9.46 M (USD)-11.78as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
54
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Shaperon
Shaperon is a publicly listed company on the KRX with ticker symbol 378800 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Shaperon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Shaperon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shaperon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shaperon Comparisons
Competitors of Shaperon
Shaperon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics, Revance Therapeutics and Alpine Immune Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shaperon
Frequently Asked Questions about Shaperon
When was Shaperon founded?
Shaperon was founded in 2008.
Where is Shaperon located?
Shaperon is headquartered in Seoul, South Korea.
Who is the current CEO of Shaperon?
Seung Yong Seong is the current CEO of Shaperon. They have also founded this company.
How many employees does Shaperon have?
As of Dec 31, 2024, the latest employee count at Shaperon is 54.
What is the annual revenue of Shaperon?
Annual revenue of Shaperon is $12K as on Dec 31, 2024.
What does Shaperon do?
Shaperon is engaged in business activities that are not detailed on the website. No specific information regarding sectors, solutions, or operational focus is provided. Further details about the companys scope and offerings are unavailable from the given content.
Who are the top competitors of Shaperon?
Shaperon's top competitors include Revance Therapeutics, Ironwood Pharma and Escient Pharmaceuticals.
Is Shaperon publicly traded?
Yes, Shaperon is publicly traded on KRX under the ticker symbol 378800.
What is Shaperon's ticker symbol?
The ticker symbol of Shaperon is 378800 on KRX.